Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Doxycycline topical gel - Ology Bioservices

Drug Profile

Doxycycline topical gel - Ology Bioservices

Alternative Names: Doxycycline gel; Doxycycline hydrogel; Doxycycline monohydrate hydrogel; NanoDOX Hydrogel

Latest Information Update: 07 Jan 2019

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nanotherapeutics
  • Developer Nanotherapeutics; Ology Bioservices
  • Class Antibacterials; Antimalarials; Skin disorder therapies; Small molecules; Tetracyclines
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Atopic dermatitis
  • No development reported Diabetic foot ulcer; Wounds

Most Recent Events

  • 30 Nov 2018 Alchem Laboratories completes a phase II trial in Atopic Dermatitis in USA (NCT02910011)
  • 02 Oct 2017 Nanotherapeutics is now called as Ology Bioservices
  • 18 May 2017 Phase-II clinical trials in Atopic dermatitis in USA (Topical) (NCT02910011)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top